Zycefta (Ceftazidime / Avibactam Vials) 2gm / 0.5gm

Zycefta is a combination antibiotic used to treat bacterial infections. It contains Ceftazidime and Avibactam, effective against certain resistant strains. This medication is available in vial form for intravenous use. Keep at room temperature away from moisture.

Strength

2gm / 0.5gm

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Zydus Cadila

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zycefta is used to treat infections caused by gram-negative bacteria, including complicated urinary tract infections and intra-abdominal infections. It may also be prescribed for pneumonia or other serious bacterial conditions when other treatments are ineffective. This combination helps target a broad spectrum of bacteria. Always consult a healthcare provider for specific use cases.

Side Effects

Zycefta works by stopping bacterial growth and preventing the spread of infection. Patients may experience improved symptoms as the medication takes effect. Common effects include reduced fever and pain associated with infections. The body’s natural response to the medication varies by individual.

Precautions & Warnings

Store Zycefta at room temperature, away from heat and moisture. Keep the vial in its original packaging until ready to use. Do not use if the vial is damaged or the solution appears discolored. Follow all handling instructions provided by your pharmacist or healthcare provider. Keep out of reach of children.

Avoid Interactions

Zycefta may interact with other medications, including certain antibiotics or blood thinners. Avoid alcohol while using this medication, as it may reduce effectiveness or increase side effects. Inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

Zycefta is used to treat bacterial infections, including complicated urinary tract and intra-abdominal infections.

Zycefta is given as an intravenous injection or infusion by a healthcare professional.

No, Zycefta is an antibiotic and only treats bacterial infections.

Common side effects may include nausea, diarrhea, or headache. Severe reactions should be reported to a doctor.

Consult a healthcare provider before using Zycefta if pregnant or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.